JA

James A. Ankrum

Fraternal Order of Eagles Diabetes Research Center, University of Iowa

Affiliated withUniversity of Iowa

Research Area

Biography

James Ankrum is an Assistant Professor in Biomedical Engineering. James got his undergraduate degree from the Univeristy of Iowa in Biomedical Engineering. He went on to earn his Masters from the University of Cambridge as the first Churchill Scholar ever selected from the University of Iowa. He earned his PhD from MIT in 2013 under the guidance of Prof. Jeff Karp, where he became fascinated with the field of regenerative medicine and cell-based therapies. After a year as a Senior Innovation Fellow at the University of Minnesota, he returned to the University of Iowa in 2014 to start his research lab in the Fraternal Order of Eagles Diabetes Research Center within the Pappajohn Biomedical Institute. Dr. Ankrum and his group use bioengineering strategies to enhance cell-based therapies for regenerative medicine, develop tissue models for drug discovery, and engineer drug release technologies for controlled drug release.

JoVE Journal Publications

ArticleTotal : 2
Year
Lentiviral Mediated Gene Silencing in Human Pseudoislet Prepared in Low Attachment Plates
Publication title

Cited by 9

2019
2025

Other Publications

Article
Year

Scientific reports| PubMed ID: 27212469

2016

Stem cells international| PubMed ID: 27703484

2016

Stem cells (Dayton, Ohio)| PubMed ID: 27758056

2017

Advances in wound care| PubMed ID: 29279805

2017

Scientific reports| PubMed ID: 29323267

2018

Molecular therapy : the journal of the American Society of Gene Therapy| PubMed ID: 29352647

2018

Physiological reports| PubMed ID: 30370689

2018

Trends in molecular medicine| PubMed ID: 30711482

2019

Cellular and molecular gastroenterology and hepatology| PubMed ID: 30926581

2019

Nature biomedical engineering| PubMed ID: 30944433

2019

Frontiers in immunology| PubMed ID: 31134100

2019

Frontiers in immunology| PubMed ID: 32133010

2020

Frontiers in immunology| PubMed ID: 32158443

2020

Diabetes| PubMed ID: 32234723

2020

Molecular metabolism| PubMed ID: 32240964

2020

Diabetes| PubMed ID: 32312867

2020

Journal of the Royal Society, Interface| PubMed ID: 32546114

2020

Scientific reports| PubMed ID: 32581231

2020

PloS one| PubMed ID: 32730300

2020

Translational vision science & technology| PubMed ID: 32855863

2020

Molecular metabolism| PubMed ID: 33358927

2021

Nature biomedical engineering| PubMed ID: 35064245

2022

Toxicology in vitro : an international journal published in association with BIBRA| PubMed ID: 35618242

2022

Stem cells translational medicine| PubMed ID: 35641163

2022

Frontiers in immunology| PubMed ID: 35860241

2022

Data in brief| PubMed ID: 36131953

2022

Environmental science & technology| PubMed ID: 36651682

2023

Toxicology in vitro : an international journal published in association with BIBRA| PubMed ID: 36804509

2023

Journal of the Royal Society, Interface| PubMed ID: 37132228

2023

Frontiers in endocrinology| PubMed ID: 37305047

2023

Data in brief| PubMed ID: 37520642

2023

Stem cell research & therapy| PubMed ID: 37592321

2023

Toxicology| PubMed ID: 37995827

2023

The Journal of clinical endocrinology and metabolism| PubMed ID: 38597153

2024

Bioengineering (Basel, Switzerland)| PubMed ID: 39061801

2024

Environmental toxicology and pharmacology| PubMed ID: 39067718

2024

Journal of hazardous materials| PubMed ID: 39369679

2024

Toxicology| PubMed ID: 39369937

2024

Cytotherapy| PubMed ID: 39580716

2025

Environmental toxicology and pharmacology| PubMed ID: 39674530

2025

Cellular and molecular bioengineering| PubMed ID: 39926384

2024

Toxicology| PubMed ID: 40097135

2025

PNAS nexus| PubMed ID: 40191133

2025

Stem cell research & therapy| PubMed ID: 40770765

2025

Diabetes| PubMed ID: 40906541

2025